A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)
Clinical trial NCT00491738 · TERMINATED
Trial details
- NCT number
- NCT00491738
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.